XianShi Pharmaceutical Group

Yunnan Xianshi Pharmaceutical is a private Chinese pharmaceutical company focused on drug R&D, manufacturing, sales, and downstream healthcare delivery. Public company-profile sources describe it as having marketed products as well as a sizable development pipeline, with activities spanning respiratory, immune, cardiovascular, orthopedic, and hematologic diseases. The company appears to operate primarily as a domestic pharma/generics business rather than a venture-stage biotech, and it also has affiliated retail and hospital assets in Yunnan. External pipeline databases specifically associate the company with teriparatide and bioequivalence programs for products such as quetiapine fumarate extended-release and tofacitinib citrate extended-release. It also appears linked to manufacturing capabilities through Hunan Xianshi Pharmaceutical, an affiliated production entity within the broader Xianshi group structure.